Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

345

HTML

2911

Figures (1-4)

180

Tables (1-4)

209

Sum=3645

Apr 15, 2002 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Esophageal Cancer

World J Gastroenterol. Apr 15, 2002; 8(2): 203-207
Published online Apr 15, 2002. doi: 10.3748/wjg.v8.i2.203

Table 3 Cell cycle of HCC and EC cells expressing EGR-1 with FCM (number of fraction)

^aP = 0.038,

^bP = 1.000,

^cP = 0.048, vs their controls

Citation: Hao MW, Liang YR, Liu YF, Liu L, Wu MY, Yang HX. Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines. World J Gastroenterol 2002; 8(2): 203-207
URL: https://www.wjgnet.com/1007-9327/full/v8/i2/203.htm
DOI: https://dx.doi.org/10.3748/wjg.v8.i2.203